Isolation of NDM-1-producing multidrug-resistant Pseudomonas putida from a paediatric case of acute gastroenteritis,

D Bhattacharya1, S Dey1, S Kadam1

  • 1Regional Medical Research Centre (Indian Council of Medical Research, Dept. of Health Research, Govt. of India), Nehru Nagar, Belgaum, Karnataka, India.

Insights

This study reports the first isolation of New Delhi metallo-beta-lactamase 1 (NDM-1)-producing, multidrug-resistant Pseudomonas putida from a patient with acute gastroenteritis. This rare pathogen displayed resistance to multiple antibiotics, including carbapenems.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Pseudomonas putida is typically susceptible to antibiotics, with limited data on resistance in clinical isolates.
  • Uncommon opportunistic pathogens can cause significant clinical infections.

Purpose of the Study:

  • To report the first isolation of New Delhi metallo-beta-lactamase 1 (NDM-1)-producing multidrug-resistant Pseudomonas putida.
  • To characterize the antimicrobial resistance profile and genetic basis of resistance in this rare isolate.

Main Methods:

  • Phenotypic antimicrobial susceptibility testing was performed.
  • Molecular methods were used to identify resistance genes, including bla NDM-1, and analyze quinolone resistance determining regions.

Main Results:

  • The Pseudomonas putida isolate was multidrug-resistant, exhibiting resistance to fluoroquinolones, third-generation cephalosporins, and carbapenems.
  • The isolate carried the bla NDM-1 gene and other resistance genes (qepA, bla TEM, bla OXA1, bla OXA7).
  • Multiple mutations were identified in the quinolone resistance determining region.

Conclusions:

  • This case highlights the emergence of NDM-1-producing multidrug-resistant Pseudomonas putida as a potential cause of gastroenteritis.
  • Clinicians should consider rare pathogens in cases where common bacteria are not identified.